Seeking Alpha

AstraZeneca plc (AZN)

()

News & PR
Market Currents

Buzz
Twitter: AZN

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

AstraZeneca: FDA Backs Crestor’s Wider Use

Dec 29 • Zacks.com • Comment!
Pharma Spreads Holiday Cheer in Bevy of Biotech Deals

Dec 24 • The Burrill Report • Comment!
Astra-Zeneca Flies to 'Jupiter' on Drug Results

Dec 6 • Larry Meyers • 6 Comments
AstraZeneca, Targacept Teaming Up for New Antidepressant

Dec 4 • Zacks.com • Comment!
BoA TARP Repayment Boosts Financial Sector

Dec 3 • optionMONSTER • Comment!
Wall Street Breakfast: Must-Know News

Dec 3 • SA Editor Eli Hoffmann • 11 Comments
H1N1: What It Means for Pharma

Dec 2 • R. Scott Raynovich • 2 Comments
AstraZeneca's Latest Cost-Cutting Move: Offshore Production

Dec 1 • ChinaBio Today • Comment!
8 HealthCare Stocks with 3%+ Dividends

Nov 29 • Hao Jin • 9 Comments
BioMed News Bytes: AstraZeneca, Delcath, Unilife

Nov 20 • Mike Havrilla • Comment!
Big Pharma Under Pressure as Drug Patents Expire and Pipeline Slows

Nov 19 • Research Recap • 1 Comment
Direction of Cholesterol Debate Could Benefit Abbott Labs

Nov 16 • EP Vantage • 1 Comment
13 British ADRs Increasing Dividend Payments

Nov 16 • David Hunkar • 4 Comments
The Top 4 Healthcare Dividend Stocks: Covered Call Trades

Nov 6 • Double Dividend Stocks • 2 Comments
A 130 / 30 Global Pharma Strategy

Nov 5 • Mike Havrilla • 2 Comments
Healthcare Profits: Assessing Company Sensitivity to Obamacare

Oct 30 • Richard Shaw • 11 Comments
Wall Street Breakfast: Must-Know News

Oct 29 • SA Editor Eli Hoffmann • 15 Comments
Incyte – Life After Debt (Part II)

Oct 19 • Ohad Hammer • Comment!
Progenics: Investors Are Right To Be Wary

Oct 14 • EP Vantage • 1 Comment
H1N1: How to Buy into the Fear

Oct 7 • Jim Van Meerten • 1 Comment
AstraZeneca: Nektar Deal to Add Value

Oct 5 • Zacks.com • Comment!
Report from Europe: M&A May Save the Day

Sep 28 • The Mole • 3 Comments
Financing Activity for Biotech Deals Heats Up

Sep 27 • The Burrill Report • 2 Comments
Closing Update for Thursday, Sept. 24: Nasdaq, Oil Lead the Decline

Sep 24 • Midnight Trader • 1 Comment
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Sep 11 • Justin M. Hall • 23 Comments
Brilinta Data Should Soothe Some of AstraZeneca's Patent Cliff Woes

Sep 2 • EP Vantage • Comment!
Closing Update for Monday, August 31: Trimming August Gains

Aug 31 • Midnight Trader • 5 Comments
Three Recent Biotech Activist Wins by Carl Icahn

Aug 31 • Michael Becker • 4 Comments
Wall Street Breakfast: Must-Know News

Aug 31 • SA Editor Rachael Granby • 16 Comments
Options Trader: August Retrospective

Aug 29 • Philip Davis • Comment!
ChinaBio Week in Review: A Victory for Traditional Chinese Medicine

Aug 23 • ChinaBio Today • 2 Comments
Incyte Presents Investors with Unique Dilemmas

Aug 10 • Ohad Hammer • 1 Comment
New Diabetes Drug Could Give Januvia Stiff Competition

Aug 4 • EP Vantage • 2 Comments
Biotech Stocks: Digging for Gold in a Swine's Snout

Aug 2 • Jay Garcilazo • 2 Comments
FDA Calendar Updates: Advanced Life Sciences, AstraZeneca, Bristol-Myers

Aug 2 • Mike Havrilla • Comment!
AstraZeneca: This Dividend Paying Stock Is Worth Another Look

Jul 30 • Capital Preserve • 1 Comment
Wall Street Breakfast: Must-Know News

Jul 30 • SA Editor Rachael Granby • 16 Comments
Earnings Bolster Global Markets: Yearly Highs in Sight

Jul 30 • The LFB • Comment!
Preview from Europe: Market Holds Up Well Despite Newsflow

Jul 30 • The Mole • 4 Comments
Lines Blur Between Biotech and Pharma

Jul 28 • Vincent Fernando • Comment!
FDA Calendar: 2H09 Binary Event Trades

Jul 27 • Mike Havrilla • 3 Comments

AstraZeneca plc (AZN)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers